News
Latest News
Australian Government response to the Senate Community Affairs References Committee report: Inquiry into Current barriers to patient access to medicinal cannabis in Australia
4 March 2021
The Australian Government response to the Inquiry into current barriers to patient access to medicinal cannabis has now been published
Introduction of the Narcotic Drugs Amendment (Medicinal Cannabis) Bill 2021
4 February 2021
Introduction of the Narcotic Drugs Amendment (Medicinal Cannabis) Bill 2021
Commission on Narcotic Drugs votes on recommendations for cannabis and cannabis related substances
10 December 2020
On 2 December 2020, Australia voted at the Commission on Narcotic Drugs on six recommendations concerning the scheduling of cannabis and cannabis related substances
Medicinal cannabis permit reform consultation
13 November 2020
The ODC is seeking comments on a review of the structure, design and administrative processes relating to medicinal cannabis related permits
Cost Recovery Implementation Statement (CRIS) - Regulation of Medicinal Cannabis 2020-21
4 November 2020
Provides information on how the Office of Drug Control implements cost recovery for regulatory activities.
Commencement of fees and charges for cannabis-related manufacture
2 November 2020
Cost recovery arrangements for cannabis-related manufacture licences and permits commenced on 1 November 2020.
Increasing consumer access to kava
7 October 2020
The Australian Government will implement a second phase of the pilot program to increase the amount of kava allowed to be imported in Australia.
Introduction of fees and charges for cannabis-related manufacture
6 October 2020
From 1 November 2020, subject to formal approval from the Federal Executive Council, cost recovery arrangements will be extended to cannabis-related manufacture licences and permits under the Medicinal Cannabis Scheme.
Controlled substances
12 August 2020
Update to list of controlled substances
Reforms to Medicinal Cannabis Scheme Fees and Charges
27 July 2020
Changes to fees and charges related to the Medicinal Cannabis Scheme under the Narcotic Drugs Act 1967 commenced on 15 July 2020